Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Patrycja Tudrej
Observed names:
P. Tudrej,
P.A. Tudrej,
Tudrej, Patrycja
Institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
Observed institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
ORCID:
0000-0003-0414-3853
Observed ORCID:
0000-0003-0414-3853
OpenAlex ID:
A5004739296
Advances in ovarian cancer therapy
2017
·
Alexander J. Cortez
, Patrycja Tudrej
, et al.
·
Cancer Chemotherapy and Pharmacology
·
712
PDF
Unsupervised analysis reveals two molecular subgroups of serous ovarian cancer with distinct gene expression profiles and survival
2016
·
Katarzyna M. Lisowska
, Magdalena Olbryt
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
66
PDF
Characteristics of in Vivo Model Systems for Ovarian Cancer Studies
2019
·
Patrycja Tudrej
, Katarzyna Aleksandra Kujawa
, et al.
·
Diagnostics
·
51
Establishment and Characterization of the Novel High-Grade Serous Ovarian Cancer Cell Line OVPA8
2018
·
Patrycja Tudrej
, Magdalena Olbryt
, et al.
·
International Journal of Molecular Sciences
·
39
PDF
Liquid biopsy utilizing miRNA in patients with advanced breast cancer treated with cyclin‑dependent kinase 4/6 inhibitors
2024
·
Marcin Kubeczko
, Patrycja Tudrej
, et al.
·
Oncology Letters
·
12
PDF
Characteristics of in vitro model systems for ovarian cancer studies
2019
·
Patrycja Tudrej
, Katarzyna Aleksandra Kujawa
, et al.
·
Oncology in Clinical Practice
·
10
PDF
Bis-anthracycline WP760 abrogates melanoma cell growth by transcription inhibition, p53 activation and IGF1R downregulation
2017
·
Magdalena Olbryt
, Aleksandra Rusin
, et al.
·
Investigational New Drugs
·
8
PDF
Integrin beta-like 1 overexpression stimulates invasiveness of ovarian cancer cells in vitro
2018
·
A.J. Cortez
, K.A. Kujawa
, et al.
·
Annals of Oncology
·
3
MiRNA in archival serum samples derived from breast cancer patients treated with neoadjuvant chemotherapy vs freshly collected samples: Pilot study
2024
·
Marcin Kubeczko
, Patrycja Tudrej
, et al.
·
Advances in Clinical and Experimental Medicine
219 Effect of olaparib treatment on cell cycle, senescence and cell death in ovarian cancer cells
2020
·
P. Tudrej
, M. Głowala-Kosińska
, et al.
·
International Journal of Gynecological Cancer
PDF
69 Detection of ITGBL1 mRNA isoforms in ovarian cancer cells
2020
·
A. Cortez
, K. Kujawa
, et al.
·
International Journal of Gynecological Cancer
PDF
Charakterystyka modeli in vitro do badań nad rakiem jajnika
2018
·
Patrycja Tudrej
, Katarzyna Aleksandra Kujawa
, et al.
·
Onkologia w Praktyce Klinicznej - Edukacja
PO-235 Integrin beta-like 1 overexpression stimulates invasiveness of ovarian cancer cells in vitro
2018
·
A.J. Cortez
, K.A. Kujawa
, et al.
·
ESMO Open
PO-134 Cytogenetic and molecular characterisation of new high-grade serous ovarian cancer cell line OVPA8
2018
·
P. Tudrej
, A. Cortez
, et al.
·
ESMO Open
Detection of Cancer Stem-like Cells in Established Ovarian Cancer Cell Lines and Tumors
2017
·
Patrycja Tudrej
In Vitro Cultured Ovarian Cancer Cells Express Extracellular Matrix-associated Gene Signature Indicative of Poor Prognosis
2016
·
Patrycja Tudrej
Show more works
View as search
Works count:
25
Citation count:
901
H-index:
7
I10-index:
6
Year
Topic
Type